SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-010487
Filing Date
2023-08-10
Accepted
2023-08-10 16:16:30
Documents
46
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q drma_10q.htm   iXBRL 10-Q 630937
2 CERTIFICATION drma_ex311.htm EX-31.1 11453
3 CERTIFICATION drma_ex312.htm EX-31.2 11279
4 CERTIFICATION drma_ex321.htm EX-32.1 7025
  Complete submission text file 0001654954-23-010487.txt   3144447

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA drma-20230630.xsd EX-101.SCH 32557
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20230630_lab.xml EX-101.LAB 186877
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20230630_cal.xml EX-101.CAL 23314
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20230630_pre.xml EX-101.PRE 161464
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20230630_def.xml EX-101.DEF 105445
40 EXTRACTED XBRL INSTANCE DOCUMENT drma_10q_htm.xml XML 481803
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40739 | Film No.: 231159710
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences